Prelude Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-45,404
Closed -$9.63M 1459
2023
Q3
$9.63M Buy
45,404
+11,814
+35% +$2.36M 0.63% 21
2023
Q2
$6.46M Buy
33,590
+12,072
+56% +$2.4M 0.42% 30
2023
Q1
$4.36M Buy
21,518
+19,759
+1,123% +$3.17M 0.26% 76
2022
Q4
$226K Sell
1,759
-7,037
-80% -$908K 0.01% 916
2022
Q3
$1.2M Sell
8,796
-2,351
-21% -$383K 0.04% 366
2022
Q2
$1.97M Buy
+11,147
New +$1.61M 0.06% 305
2021
Q2
Sell
-2,140
Closed -$297K 2060
2021
Q1
$297K Buy
+2,140
New +$345K 0.01% 1155
2020
Q3
Sell
-556
Closed -$94K 2487
2020
Q2
$94K Sell
556
-232
-29% -$34.6K 0.01% 977
2020
Q1
$91K Sell
788
-4,752
-86% -$526K 0.01% 622
2019
Q4
$633K Sell
5,540
-745
-12% -$79K 0.02% 498
2019
Q3
$537K Buy
+6,285
New +$461K 0.02% 499
2019
Q2
Sell
-323
Closed -$24K 2243
2019
Q1
$24K Buy
+323
New +$23K ﹤0.01% 1288
2018
Q1
Sell
-294
Closed -$16K 1773
2017
Q4
$16K Buy
+294
New +$17.2K ﹤0.01% 1166
2017
Q3
Sell
-4,135
Closed -$214K 1963
2017
Q2
$214K Buy
4,135
+470
+13% +$29.9K 0.02% 555
2017
Q1
$230K Buy
3,665
+875
+31% +$54.6K 0.02% 522
2016
Q4
$147K Buy
2,790
+2,135
+326% +$128K 0.02% 689
2016
Q3
$35K Sell
655
-48
-7% -$2.28K ﹤0.01% 1166
2016
Q2
$28K Sell
703
-4,861
-87% -$185K ﹤0.01% 1178
2016
Q1
$195K Sell
5,564
-7,660
-58% -$257K 0.03% 563
2015
Q4
$593K Buy
13,224
+3,469
+36% +$144K 0.09% 242
2015
Q3
$376K Sell
9,755
-786
-7% -$35.4K 0.05% 354
2015
Q2
$510K Sell
10,541
-2,230
-17% -$92K 0.07% 304
2015
Q1
$451K Buy
12,771
+4,358
+52% +$149K 0.06% 375
2014
Q4
$270K Buy
+8,413
New +$293K 0.04% 533
2014
Q2
Sell
-12,042
Closed -$549K 2230
2014
Q1
$549K Buy
12,042
+4,625
+62% +$221K 0.07% 366
2013
Q4
$296K Buy
7,417
+900
+14% +$36.7K 0.05% 507
2013
Q3
$286K Sell
6,517
-9,839
-60% -$410K 0.05% 431
2013
Q2
$515K Buy
+16,356
New +$571K 0.11% 247

Other funds holding SGEN

Prelude Capital Management's SGEN Position: Q4 2023 in Review

Prelude Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 45,404 shares — an estimated $9.63M sold.

Prelude Capital Management first reported a position in SGEN in Q2 2013 and held it in 28 quarters. The position peaked at $9.63M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Prelude Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 45,404 Seagen Inc. Common Stock shares in Q4 2023, an estimated $9.63M.
  • Prelude Capital Management first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 28 quarters.
  • Prelude Capital Management's Seagen Inc. Common Stock position peaked at $9.63M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.